Int J Mol Sci, 2021, 22(8)

Htert-driven immortalization of rdeb fibroblast and keratinocyte cell lines followed by cre-mediated transgene elimination

The recessive form of dystrophic epidermolysis bullosa (RDEB) is a crippling disease caused by impairments in the junctions of the dermis and the basement membrane of the epidermis. Using ectopic expression of hTERT/hTERT + BMI-1 in primary cells, we developed expansible cultures of RDEB fibroblasts and keratinocytes. We showed that they display the properties of their founders, including morphology, contraction ability and expression of the respective specific markers including reduced secretion of type VII collagen (C7). The immortalized keratinocytes retained normal stratification in 3D skin equivalents. The comparison of secreted protein patterns from immortalized RDEB and healthy keratinocytes revealed the differences in the contents of the extracellular matrix that were earlier observed specifically for RDEB. We demonstrated the possibility to reverse the genotype of immortalized cells to the state closer to the progenitors by the Cre-dependent hTERT switch off. Increased β-galactosidase activity and reduced proliferation of fibroblasts were shown after splitting out of transgenes. We anticipate our cell lines to be tractable models for studying RDEB from the level of single-cell changes to the evaluation of 3D skin equivalents. Our approach permits the creation of standardized and expandable models of RDEB that can be compared with the models based on primary cell cultures.

Evtushenko NA, Beilin AK, Dashinimaev EB, Ziganshin RH, Kosykh AV, Perfilov MM, Rippa AL, Alpeeva EV, Vasiliev AV, Vorotelyak EA, Gurskaya NG

IBCH: 9185
Ссылка на статью в журнале: https://www.mdpi.com/1422-0067/22/8/3809
Кол-во цитирований на 04.2024: 3
Данные статьи проверены модераторами 2021-05-02

Список научных проектов, где отмечена публикация

  1. 19-29-04044. . Внебюджетное финансирование.
  2. 19-34-90066. . Внебюджетное финансирование.
  3. ЦКП ИБХ (6 Января 2019 года — 31 Декабря 2022 года). . Внебюджетное финансирование.